Fatal methadone intoxication in a 11-month-old male infant

J Sidlo1, J Valuch, P Ocko

  • 1Institute of Forensic Medicine, School of Medicine, Comenius University and Health Care Surveillance Authority, Bratislava, Slovakia.

Soudni Lekarstvi
|June 19, 2009
PubMed

Insights

Fatal methadone intoxication caused the unexpected death of an 11-month-old infant. This rare pediatric case highlights the importance of toxicological analysis in diagnosing methadone poisoning when clinical signs are absent.

Area of Science:

  • Forensic Toxicology
  • Pediatric Pathology

Background:

  • Adult methadone intoxication cases are rising with opiate substitution therapy.
  • Pediatric methadone intoxication is rare and diagnostically challenging based on clinical presentation alone.

Observation:

  • An 11-month-old infant presented with sudden, unexplained death.
  • Autopsy revealed non-specific morphological findings.
  • Toxicological analysis detected methadone in blood, liver, kidney, and urine.

Findings:

  • Methadone was confirmed as the cause of death in the infant.
  • Ethanol and other psychoactive substances were not detected.
  • Methadone concentrations were significant: blood serum 1.3 µg/mL, liver 5.0 µg/g, kidney 2.6 µg/g, urine 3.2 µg/mL.

Implications:

  • This case underscores the potential for accidental or intentional methadone administration to infants.
  • The source of methadone remains unknown, suggesting administration by an external party.
  • Highlights the critical role of forensic toxicology in identifying causes of death in infants, especially in suspected intoxication cases.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...